A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Lifevantage Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 26,200 shares of LFVN stock, worth $454,832. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,200
Holding current value
$454,832
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.51 - $13.01 $19,510 - $46,068
3,541 New
3,541 $42,000
Q4 2023

Feb 14, 2024

SELL
$4.38 - $8.25 $11,484 - $21,631
-2,622 Reduced 71.86%
1,027 $6,000
Q3 2023

Nov 14, 2023

SELL
$4.22 - $7.51 $51,462 - $91,584
-12,195 Reduced 76.97%
3,649 $23,000
Q2 2023

Aug 14, 2023

SELL
$3.04 - $5.5 $17,863 - $32,318
-5,876 Reduced 27.05%
15,844 $68,000
Q1 2023

May 15, 2023

SELL
$3.26 - $4.0 $34,370 - $42,172
-10,543 Reduced 32.68%
21,720 $77,000
Q4 2022

Feb 14, 2023

BUY
$3.63 - $4.03 $117,114 - $130,019
32,263 New
32,263 $120,000
Q3 2021

Nov 15, 2021

SELL
$6.5 - $8.38 $539,363 - $695,364
-82,979 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$6.9 - $9.59 $264,953 - $368,246
38,399 Added 86.14%
82,979 $609,000
Q1 2021

May 17, 2021

BUY
$8.58 - $10.21 $65,662 - $78,137
7,653 Added 20.72%
44,580 $416,000
Q4 2020

Feb 16, 2021

SELL
$9.32 - $13.4 $155,932 - $224,195
-16,731 Reduced 31.18%
36,927 $344,000
Q3 2020

Nov 16, 2020

BUY
$12.07 - $15.31 $228,473 - $289,802
18,929 Added 54.5%
53,658 $647,000
Q2 2020

Aug 14, 2020

SELL
$10.25 - $16.54 $82,912 - $133,792
-8,089 Reduced 18.89%
34,729 $470,000
Q1 2020

May 15, 2020

BUY
$7.91 - $16.96 $209,464 - $449,117
26,481 Added 162.09%
42,818 $441,000
Q4 2018

Feb 14, 2019

SELL
$10.06 - $14.87 $6,991 - $10,334
-695 Reduced 4.08%
16,337 $215,000
Q3 2018

Nov 13, 2018

BUY
$6.33 - $13.02 $107,812 - $221,756
17,032 New
17,032 $0

Others Institutions Holding LFVN

About Lifevantage Corp


  • Ticker LFVN
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Packaged Foods
  • Shares Outstandng 12,560,000
  • Market Cap $218M
  • Description
  • LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically va...
More about LFVN
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.